Targeting FGFR1 enhances olaparib sensitivity via MAPK-mediated BRCA2 downregulation in mCRPC
Jian Ping Chen(First Affiliated Hospital of Guangzhou Medical University), Weide Zhong(Guangzhou First People's Hospital), Jiarun Lai(First Affiliated Hospital of Guangzhou Medical University), Shaoyou Liu(Macau University of Science and Technology), Zhaodong Han(Guangzhou Women and Children Medical Center), Huichan He(First Affiliated Hospital of Guangzhou Medical University), Jiaming Su(Beijing University of Chinese Medicine), Rui Zhou(First Affiliated Hospital of Guangzhou Medical University), Ziqing Zhou(Air Force Medical University)
Cited by 0
Related Papers
Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
|OncoTargets and Therapy|2016|120
Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma
|Journal of Cellular Physiology|2019|74
E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer
|International Journal of Oncology|2016|59
CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer
|BioMed Research International|2014|47
Patterns of Immune Infiltration in HNC and Their Clinical Implications: A Gene Expression-Based Study
|Frontiers in Oncology|2019|40